Individuals from DPRK have been identified as infiltrating European organizations, posing potential threats to national security. This raises concerns about the motivation and intentions of these infiltrators. The exact number of infiltrators and the extent of their influence within these organizations are still unknown.
Bridging Technologies Renew Hope for Treating Inflammatory Diseases
Kiji Therapeutics is developing a therapeutic to treat autoimmune diseases, using genetically engineered mesenchymal stem cells to improve potency and targeting. The drug is targeted
